# Fate Therapeutics Inc: Form 8-K, filed Mar 21, 2024

- Company: [Fate Therapeutics Inc](/companies/fate.md) (CIK 1434316)
- Form: 8-K
- Filed: 2024-03-21
- Accepted by EDGAR: Mar 20, 2024, 17:32 ET
- Period: 2024-03-19
- Accession: 0001193125-24-072871
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1434316/000119312524072871/d799248d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1434316/000119312524072871/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1434316/000119312524072871/d799248d8k.htm

Filed Mar 21, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-072871. Last ingested by Listed: Nov 5, 2026, 19:31 ET. No prices; not investment advice.